ISSN Print 2500–1094
ISSN Online 2542–1204
BIOMEDICAL JOURNAL OF PIROGOV UNIVERSITY (MOSCOW, RUSSIA)
ORIGINAL RESEARCH
LoRI, a new recombinant RNase inhibitor for in vitro applications
About authors
1 DNA-Technology LLC, 117587, Moscow, Russia
2 MIREA — Russian Technological University, Moscow, Russia
3 Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry RAS, Moscow, Russia
4 Bauman Moscow State Technical University, Moscow, Russia
5 Pirogov Russian National Research Medical University, Moscow, Russia
Correspondence should be addressed: Natalia Yu. Usman
Ostrovityanova 1/1, Moscow, 117997, Russia; ur.relbmar@namsu_n
About paper
Funding: The study was funded by DNA-Technology LLC.
Author contribution: Sukhov DA, Romanenko GA — protein engineering, expression and purification; Kholoshenko IV, Petrova TV — product characterization, writing; Myshkin MYu — protein structure analysis; Kost VYu — study design; Trofimov DYu — project supervision; Usman NYu — writing; Barsova EV — project coordination, writing.
Received: 2024-09-02
Accepted: 2024-10-09
Published online: 2024-10-28